Hongbo Li

Papers

Total Citations

187

H-Index

About

Hongbo Li is a prominent researcher specializing in urologic oncology, with a particular focus on the epidemiology and clinical landscape of urological cancers in China. His most influential work, "Urologic Cancer in China" (2016), has garnered 187 citations and stands as a landmark contribution to understanding the burden of bladder and prostate cancers within the Chinese population. By leveraging data from the National Central Cancer Registry of China, Li helped illuminate the rising incidence and mortality trends of these malignancies, providing a critical foundation for public health policy and clinical strategy in one of the world's most populous nations. His research addresses a pressing gap in the global oncology literature, where data specific to Chinese patients has historically been underrepresented. Through rigorous epidemiological analysis, Li has shaped how clinicians, policymakers, and researchers understand urologic cancer patterns in Asia. His work serves as an essential reference for those studying cancer disparities, population-level disease burden, and the unique demographic factors influencing urological malignancies in China, making him a significant voice in both regional and international cancer research communities.